154 related articles for article (PubMed ID: 6387262)
1. Deterioration of renal function in hypertensive patients with scleroderma despite blood pressure normalization with captopril.
Waeber B; Schaller MD; Wauters JP; Brunner HR
Klin Wochenschr; 1984 Aug; 62(15):728-30. PubMed ID: 6387262
[TBL] [Abstract][Full Text] [Related]
2. Clinical course of patients with scleroderma renal crisis treated with captopril.
Zawada ET; Clements PJ; Furst DA; Bloomer HA; Paulus HE; Maxwell MH
Nephron; 1981; 27(2):74-8. PubMed ID: 7022235
[TBL] [Abstract][Full Text] [Related]
3. Variable response to oral angiotensin-converting-enzyme blockade in hypertensive scleroderma patients.
Whitman HH; Case DB; Laragh JH; Christian CL; Botstein G; Maricq H; Leroy EC
Arthritis Rheum; 1982 Mar; 25(3):241-8. PubMed ID: 6279117
[TBL] [Abstract][Full Text] [Related]
4. Failure of captopril to reverse the renal crisis of scleroderma.
Brown EA; Macgregor GA; Maini RN
Ann Rheum Dis; 1983 Feb; 42(1):52-3. PubMed ID: 6338841
[TBL] [Abstract][Full Text] [Related]
5. [Administration of angiotensin I converting enzyme inhibitor captopril, in a case of renal crisis of scleroderma--the effects of captopril to the temperature of the skin lesion in scleroderma (author's transl)].
Gotoh S; Ogihara T; Hata T; Maruyama A; Naka T; Nakamaru M; Mikami H; Masuo K; Kumahara Y
Nihon Jinzo Gakkai Shi; 1981 Aug; 23(8):1133-41. PubMed ID: 7033607
[No Abstract] [Full Text] [Related]
6. Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition.
Atkinson AB; Morton JJ; Brown JJ; Davies DL; Fraser R; Kelly P; Leckie B; Lever AF; Robertson JI
Br Heart J; 1980 Sep; 44(3):290-6. PubMed ID: 7000102
[TBL] [Abstract][Full Text] [Related]
7. Captopril in the treatment of scleroderma renal crisis.
Thurm RH; Alexander JC
Arch Intern Med; 1984 Apr; 144(4):733-5. PubMed ID: 6370160
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of severe arterial hypertension with captopril (SQ 14.225) (author's transl)].
Di Giulio S; Perez-Ramirez JL; Jamoun P; Grünfeld JP; Meyer P
Nouv Presse Med; 1981 Apr; 10(19):1551-5. PubMed ID: 6269557
[TBL] [Abstract][Full Text] [Related]
9. Hypertensive crisis in systemic sclerosis: treatment with the new oral angiotensin converting enzyme inhibitor MK, 421 (Enalapril) in captopril-intolerant patients.
Smith CD; Smith RD; Korn JH
Arthritis Rheum; 1984 Jul; 27(7):826-8. PubMed ID: 6331462
[No Abstract] [Full Text] [Related]
10. Effects of the angiotensin converting enzyme inhibitor, captopril, in essential hypertension.
Campbell BC; Shepherd AN; Reid JL
Br J Clin Pharmacol; 1982 Feb; 13(2):213-7. PubMed ID: 6277356
[TBL] [Abstract][Full Text] [Related]
11. Captopril, an orally active angiotensin I converting enzyme inhibitor in the treatment of renovascular and essential hypertension.
Holtzman E; Rosenthal T; Stern N; Knecht A; Yaron A
Isr J Med Sci; 1982 May; 18(5):597-602. PubMed ID: 6284678
[TBL] [Abstract][Full Text] [Related]
12. Treatment of moderate to severe hypertensive patients with an orally active converting-enzyme inhibitor.
Prins EJ; Donker AJ; Hoorntje SJ; Leenen FH; van der Hem GK
Proc Eur Dial Transplant Assoc; 1979; 16():603-9. PubMed ID: 232914
[TBL] [Abstract][Full Text] [Related]
13. [Value of captopril in the treatment of systemic arterial and pulmonary hypertension with increased plasma renin in scleroderma].
Richard C; Ricome JL; Lemoine F; Rimailho A; Lantz O; Auzépy P
Rev Med Interne; 1983 Jun; 4(2):125-9. PubMed ID: 6351212
[TBL] [Abstract][Full Text] [Related]
14. Monotherapy of hypertension with angiotensin-converting enzyme inhibitors.
Materson BJ
Am J Med; 1984 Oct; 77(4A):128-34. PubMed ID: 6207725
[TBL] [Abstract][Full Text] [Related]
15. Prediction of sustained antihypertensive efficacy of chronic captopril therapy: relationships to immediate blood pressure response and control plasma renin activity.
Waeber B; Gavras I; Brunner HR; Cook CA; Charocopos F; Gavras HP
Am Heart J; 1982 Mar; 103(3):384-90. PubMed ID: 6278905
[TBL] [Abstract][Full Text] [Related]
16. Acute and chronic treatment of severe and malignant hypertension with the oral angiotensin-converting enzyme inhibitor captopril.
Case DB; Atlas SA; Sullivan PA; Laragh JH
Circulation; 1981 Oct; 64(4):765-71. PubMed ID: 6168412
[TBL] [Abstract][Full Text] [Related]
17. Hypertension and renal failure (scleroderma renal crisis) in progressive systemic sclerosis. Review of a 25-year experience with 68 cases.
Traub YM; Shapiro AP; Rodnan GP; Medsger TA; McDonald RH; Steen VD; Osial TA; Tolchin SF
Medicine (Baltimore); 1983 Nov; 62(6):335-52. PubMed ID: 6355755
[TBL] [Abstract][Full Text] [Related]
18. [Successful use of angiotensin II receptor antagonist (losartan) in a patient with scleroderma renal crisis].
Hasegawa S; Iesato K; Tsukahara T; Yamamoto S; Kondou Y; Ogawa M; Ueda S
Nihon Jinzo Gakkai Shi; 2000 Feb; 42(2):60-5. PubMed ID: 10771577
[TBL] [Abstract][Full Text] [Related]
19. Comparison of captopril (SQ 14225) with hydrochlorothiazide in the treatment of essential hypertension.
Aberg H; Frithz G; Mörlin C
Int J Clin Pharmacol Ther Toxicol; 1981 Aug; 19(8):368-71. PubMed ID: 7030977
[TBL] [Abstract][Full Text] [Related]
20. Reversal of scleroderma renal crisis for more than two years in a patient treated with captopril.
Sorensen LB; Paunicka K; Harris M
Arthritis Rheum; 1983 Jun; 26(6):797-801. PubMed ID: 6344871
[No Abstract] [Full Text] [Related]
[Next] [New Search]
